Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases

Paulina Núñez F., Rodrigo Quera, Constanza Bay, Pamela Thomson

Research output: Contribution to journalReview articlepeer-review

Abstract

Fecal microbiota transplant (FMT) is currently recommended for recurrent Clostridioides difficile infection. However, it is interesting to acknowledge the potential therapeutic role in other diseases associated with dysbiosis. This review will focus on the current and potential indications of FMT in gastrointestinal diseases, evaluating the available evidence and also exposing the necessary requirements to carry it out.

Translated title of the contributionFecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases
Original languageSpanish
JournalGastroenterologia y Hepatologia
DOIs
StateAccepted/In press - 2021

Bibliographical note

Publisher Copyright:
© 2021 Elsevier España, S.L.U.

Fingerprint

Dive into the research topics of 'Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases'. Together they form a unique fingerprint.

Cite this